NGL Fine-Chem Ltd
Company Profile
Business description
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
Contact
301, E Square, Subhash Road
Vile Parle (East)
MumbaiMH400057
INDT: +91 2240842222
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2026
Employees
523
Stocks News & Analysis
stocks
Oracle shares are up 87% in 2025. Is it a buy?
stocks
Is there a long-term buying opportunity in luxury stocks?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,137.80 | 14.90 | 0.16% |
CAC 40 | 7,830.11 | 23.48 | -0.30% |
DAX 40 | 23,527.05 | 112.36 | -0.48% |
Dow JONES (US) | 46,381.54 | 66.27 | 0.14% |
FTSE 100 | 9,226.68 | 10.01 | 0.11% |
HKSE | 26,080.96 | 263.18 | -1.00% |
NASDAQ | 22,788.98 | 157.50 | 0.70% |
Nikkei 225 | 45,493.66 | 447.85 | 0.99% |
NZX 50 Index | 13,136.54 | 5.00 | -0.04% |
S&P 500 | 6,693.75 | 29.39 | 0.44% |
S&P/ASX 200 | 8,845.90 | 14.30 | 0.16% |
SSE Composite Index | 3,794.27 | 34.31 | -0.90% |